Board of directors |
Ola Flink PhD MD, Chairman of the boardPharmacist. Brings experience from more than 30 years in the pharmaceutical drug development industry, including AstraZeneca, Apoteksbolaget, ACO Läkemedel and Kabi. Deputy member of the board of directors of Kampavata AB. Previous appointments include CEO and board member of Karolinska Institutet Innovations AB. Ole-Martin Gulliksen PhDBertil Ekström, Dr.rer.nat., Ass. Prof.Organic chemist. Involved in and leading anti-infective R&D at Astra AB for more than 35 years. Thereafter appointments as consultant to AstraZeneca and several start-up companies in the anti-infective field. Janne HolmiaAssociate at Verdane Capital AS. Previous experience from Standard & Poor’s and Synovus Investment Advisors (US). |
